Modeling determinants of health expenditures in Malaysia: Evidence from time series analysis

Frontiers in Pharmacology

Volumn 7, Issue MAR, 2016, Pages

  Khan, Habib N ^a   Razali, Radzuan B ^a   Shafie, Afza B ^a  

^a PETRONAS CARIGALI SDN BHD   (Malaysia)

Author keywords

Auto regressive distributed lag model; Diagnostic tests; Driving forces; Dynamic relationship; Granger causality; Health care expenditure; Model specification

Indexed keywords

AGING; ARTICLE; AUTOREGRESSIVE DISTRIBUTED LAG MODEL; ECONOMIC DEVELOPMENT; ENGLE GRANGER METHOD; HEALTH CARE; HEALTH CARE COST; HUMAN; HYPOTHESIS; INCOME; MALAYSIA; MEDICAL TECHNOLOGY; ORDINARY LEAST SQUARE REGRESSION; POPULATION GROWTH; POPULATION STRUCTURE; PRODUCTIVITY; STATISTICAL ANALYSIS; STATISTICAL MODEL; SUSTAINABLE DEVELOPMENT; TIME SERIES ANALYSIS; TREND STUDY; UNIT ROOT TEST;

EID: 84966335417     PISSN: None     EISSN: 16639812     Source Type: Journal    
DOI: 10.3389/fphar.2016.00069     Document Type: Article

References (62)

1. Baker, L. C., and Wheeler, S. K. (1998). Managed care and technology diffusion: the case of MRI. Health Aff. 17, 195-207. doi: 10.1377/hlthaff.17.5.195
2. Bech, M., Christiansen, T., Khoman, E., Lauridsen, J., and Weale, M. (2011). Ageing and health care expenditure in EU-15. Eur. J. Health Econ. 12, 469-478. doi: 10.1007/s10198-010-0260-4
3. Bodenheimer, T. (2005). High and rising health care costs. Part 2: technologic innovation. Ann. Intern. Med. 142, 932-937. doi: 10.7326/0003-4819-142-11-200506070-00012
4. Breyer, F., and Felder, S. (2006). Life expectancy and health care expenditures: a new calculation for germany using the costs of dying. Health Pol. 75, 178-186. doi: 10.1016/j.healthpol.2005.03.011
5. Chandra, A., and Skinner, J. (2012). Technology growth and expenditure growth in health care. J. Econ. Lit. 50, 645-680. doi: 10.1257/jel.50.3.645
6. Coile, C., Diamond, P., Gruber, J., and Jousten, A. (2002). Delays in claiming social security benefits. J. Public Econ. 84, 357-385. doi: 10.1016/S0047-2727(01)00129-3
7. Culyer, A. J. (1989). Cost containment in Europe. Health Care Financ. Rev. Ann. 1989(Suppl), 21-32.
8. Cuyler, A. J. (1988). Helath Care Expenditure in Canada: Myth and Reality; Past and Future. Tax Paper No.82, Candian Tax Foundation.
9. Di Matteo, L. (2003). The income elasticity of health care spending. A comparison of parametric and nonparametric approaches. Eur. J. Health Econ. 4, 20-29. doi: 10.1007/s10198-002-0141-6
10. Di Matteo, L. (2004). What drives provincial health expenditure? Can. Tax J. Revenue Fiscal Canadienne Can. Tax J. 52:1102.
11. Di Matteo, L., and Di Matteo, R. (1998). Evidence on the determinants of canadian provincial government health expenditures: 1965-1991. J. Health Econ. 17, 211-28. doi: 10.1016/S0167-6296(97)00020-9
12. Dormont, B., Grignon, M., and Huber, H. (2006). Health expenditure growth: reassessing the threat of ageing. Health Econ. 15, 947-963. doi: 10.1002/hec.1165
13. Dreger, C. (2005). "Health care expenditures in OECD countries: a panel unit root and cointegration analysis, " in International Journal of Applied Econometrics and Quantitative Studies 2, 5-20 IZA Discussion Paper no. 1469.
14. Erdil, E., and Yetkiner, I. H. (2009). The granger-causality between health care expenditure and output: a panel data approach. Appl. Econ. 41, 511-518. doi: 10.1080/00036840601019083
15. Gbesemete, K. P., and Gerdtham, U.-G. (1992). Determinants of health care expenditure in africa: a cross-sectional study. World Dev. 20, 303-308. doi: 10.1016/0305-750X(92)90108-8
16. Gerdtham, U. G., Jönsson, B., MacFarlan, M., and Oxley, H. (1998). The determinants of health expenditure in the OECD countries: a pooled data analysis. Dev. Health Econ. Public Pol. 6, 113-134. doi: 10.1007/978-1-4615-5681-7_6
17. Gerdtham, U. G., and Löthgren, M. (2000). On stationarity and cointegration of international health expenditure and GDP. J. Health Econ. 19, 461-475. doi: 10.1016/S0167-6296(99)00036-3
18. Gerdtham, U. G., Søgaard, J., Andersson, F., and Jönsson, B. (1992a). An econometric analysis of health care expenditure: a cross-section study of the OECD countries. J. Health Econ. 11, 63-84. doi: 10.1016/0167-6296(92)90025-V
19. Gerdtham, U. G., Søgaard, J., Jönsson, B., and Andersson, F. (1992b). A pooled cross-section analysis of the health care expenditures of the OECD countries. Dev. Health Econ. Public Pol. 1, 287-310. doi: 10.1007/978-94-011-2392-1_14
20. Getzen, T. E. (2014). "Measuring and forecasting global health expenditures, " in Global Health Economics and Policy, ed R. Scheffler (Singapore: World Scientific). Available online at: http://ssrn.com/abstract=2542826.
21. Granger, C. W. J. (1969). Investigating causal relations by econometric models and cross-spectral methods. Econometrica 37, 424-438. doi: 10.2307/1912791
22. Grossman, M. (1972). On the concept of health capital and the demand for health. J. Pol. Econ. 80, 223. doi: 10.1086/259880
23. Häkkinen, U., Martikainen, P., Noro, A., Nihtilä, E., and Peltola, M. (2008). Aging, health expenditure, proximity to death, and income in finland. Health Econ. Pol. Law 3(Pt 2). 165-195. doi: 10.1017/s174413310800443x
24. Hogan, C., Lunney, J., Gabel, J., and Lynn, J. (2001). Medicare beneficiaries' costs of care in the last year of life. Health Affairs 20, 188-195. doi: 10.1377/hlthaff.20.4.188
25. Hoover, D. R., Crystal, S., Kumar, R., Sambamoorthi, U., and Cantor, J. C. (2002). Medical expenditures during the last year of life: findings from the 1992-1996 medicare current beneficiary survey. Health Serv. Res. 37, 1625-1642. doi: 10.1111/1475-6773.01113
26. Jakovljevic, M. (2016). Comparison of historical medical spending patterns among the BRICS and G7. J. Med. Econ. 19, 70-76. doi: 10.3111/13696998.2015.1093493
27. Jakovljevic, M. B. (2015). Targeted immunotherapies overtaking emerging oncology market value based growth. JBUON 1, 348-353.
28. Jakovljevic, M. B., and Milovanovic, O. (2015). Growing burden of non-communicable diseases in the emerging health markets: the case of BRICS. Front. Public Health 3:65. doi: 10.3389/fpubh.2015.00065
29. Jakovljevic, M., Zugic, A., Rankovic, A., and Dagovic, A. (2014). Radiation therapy remains the key cost driver of oncology inpatient treatment. J. Med. Econ. 18, 29-36. doi: 10.3111/13696998.2014.971162
30. Junglas, I., Abraham, C., and Ives, B. (2009). Mobile technology at the frontlines of patient care: understanding fit and human drives in utilization decisions and performance. Dec. Support Syst. 46, 634-647. doi: 10.1016/j.dss.2008.11.012
31. Khan, H. N., Khan, M. A., Razli, R. B., Sahfie, A. B., Shehzada, G., Krebs, K. L., et al. (2015). Health care expenditure and economic growth in SAARC countries (1995-2012): a panel causality analysis. Appl. Res. Q. Life (ISQOLS) 1-23. doi: 10.1007/s11482-015-9385-z
32. Kleiman, E. (1974). "The determinants of national outlay on health, " in The Economics of Health and Medical Care, ed M. Perlman (London: Macmillan).
33. Kovacevic, A., Dragojevic-Simic, V., Rancic, N., Jurisevic, M., Gutzwiller, F., Matter-Walstra, K., et al. (2015). End-of-life costs of medical care for advanced stage cancer patients. Vojnosanitetski Pregled 74, 334-341. doi: 10.2298/VSP1504334K
34. Leu, R. R. (1986). "The public-private mix and international health care costs, " in Public and Private Health Services, eds A. J. Culyer and B. Jonsson (Oxford: Basil Blackwell).
35. Leu, R. R. (1987). "Public and private health services, " in Chapter the Public-Private Mix and International Health Care Cost (Oxford: Basil Blackwell).
36. Lubitz, J. (2005). Health, technology, and medical care spending. Health Affairs 24(suppl. 2), W5R81-W5R85. doi: 10.1377/hlthaff.w5.r81
37. Lubitz, J., Beebe, J., and Baker, C. (1995). Longevity and medicare expenditures. New Engl. J. Med. 332, 999-1003. doi: 10.1056/NEJM199504133321506
38. Madsen, J., Serup-Hansen, N., Kragstrup, J., and Kristiansen, I. S. (2002). Ageing may have limited impact on future costs of primary care providers. Scand. J. Prim. Health Care 20, 169-173. doi: 10.1080/028134302760234636
39. Mao, R., and Xu, J. (2014). Population aging, consumption budget allocation and sectoral growth. China Econ. Rev. 30, 44-65. doi: 10.2298/vsp1504334k
40. Martins, J. O., Joaquim, C. D. L. M., and Bjørnerud, S. (2006). Projecting OECD Health and Long-Term Care Expenditures: What Are the Main Drivers. Economics Department Working Papers No, 477. doi: 10.1787/736341548748
41. MOH (2014). Health Expenditure Report 1997-2012. Available online at: www.moh.gov.my
42. Newhouse, J. P. (1977). Medical-care expenditure: a cross-national survey. J. Hum. Resour. 12, 115-125. doi: 10.2307/145602
43. Newhouse, J. P. (1992). Medical care costs: how much welfare loss? J. Econ. Perspect. 6, 3-21. doi: 10.1257/jep.6.3.3
44. Ogura, S., and Jakovljevic, M. (2014). Health financing constrained by population aging-an opportunity to learn from japanese experience. Serbian J. Exp. Clin. Res. 15, 175-229. doi: 10.2478/sjecr-2014-0022
45. Okunad, A. A., and Murthy, V. N. R. (2002). Technology as a 'major driver' of health care costs: a cointegration analysis of the newhouse conjecture. J. Health Econ. 21, 147-159. doi: 10.1016/S0167-6296(01)00122-9
46. Palangkaraya, A., and Yong, J. (2009). Population ageing and its implications on aggregate health care demand: empirical evidence from 22 OECD countries. Int. J. Health Care Finance Econ. 9, 391-402. doi: 10.1007/s10754-009-9057-3
47. Parkin, D., McGuire, A., and Yule, B. (1987). Aggregate health care expenditures and national income: is health care a luxury good? J. Health Econ. 6, 109-127. doi: 10.1016/0167-6296(87)90002-6
48. Przywara, B. (2010). Projecting future health care expenditure at european level: drivers, methodology and main results. Econ. Papers 417. doi: 10.2765/42844
49. Rankovic, A., Rancic, N., Jovanovic, M., Ivanovic, M., Gajovic, O., Lazic, Z., et al. (2013). Impact of imaging diagnostics on the budget: are we spending too much? Vojnosanitetski Pregled 7, 709-711. Available online at: http://ssrn.com/abstract=2376767
50. Reinhardt, U. E. (2003). Does the aging of the population really drive the demand for health care? Health Affairs 22, 27-39. doi: 10.1377/hlthaff.22.6.27
51. Sachs, J. D. (2002). Macroeconomics and health: investing in health for economic development. Rev. Panam. Salud Pública 12, 143-144. doi: 10.1590/S1020-49892002000800017
52. Schulz, E., Leidl, R., and König, H.-H. (2004). The impact of ageing on hospital care and long-term care-the example of germany. Health Policy 67, 57-74. doi: 10.1016/S0168-8510(03)00083-6
53. Seshamani, M., and Gray, A. M. (2004). A longitudinal study of the effects of age and time to death on hospital costs. J. Health Econ. 23, 217-235. doi: 10.1016/j.jhealeco.2003.08.004
54. Sorenson, C., Drummond, M., and Bhuiyan Khan, B. (2013). Medical technology as a key driver of rising health expenditure: disentangling the relationship. Clin. Econ. Outcomes Res. 5, 223-234. doi: 10.2147/CEOR.S39634
55. Spillman, B. C., and Lubitz, J. (2000). The effect of longevity on spending for acute and long-term care. New Engl. J. Med. 342, 1409-1415. doi: 10.1056/NEJM200005113421906
56. Tchoe, B., and Nam, S.-H. (2010). Aging risk and health care expenditure in korea. Int. J. Environ. Res. Public Health 7, 3235-3254. doi: 10.3390/ijerph7083235
57. Thorpe, K. E., Florence, C. S., Howard, D. H., and Joski, P. (2004). The impact of obesity on rising medical spending. Health Aff. (Millwood). W4-480-W4-486. doi: 10.1377/hlthaff.w4.480
58. United States Congressional Budget Office (2007). "The Long-Term Outlook for Health Care Spending, " in A CBO Study, USA vi, 23, 4.
59. Weil, D. N. (2007). Accounting for the effect of health on economic growth. Q. J. Econ. 122, 1265-1306. doi: 10.1162/qjec.122.3.1265
60. WHO (2013). The World Health Report 2013 (World Health Organization Press), 146. Available online at: http://www.who.int/GHO/
61. World Bank Group. (2014). World Development Indicators. WDI. doi: 10.1596/978-0-8213-7386-6
62. Zweifel, P., Felder, S., and Meiers, M. (1999). Ageing of population and health care expenditure: a red herring? Health Econ. 8, 485-496.